Associations between C-reactive protein and circulating cell adhesion molecules in patients with unstable angina

Young-Cheoul Doo1, Sang-Jin Han, Woo-Jung Park

  • 1Division of Cardiology, Department of Internal Medicine, Kang-Dong Sacred Heart Hospital, College of Medicine, Hallym University, Seoul, Korea. ycdoo97@yahoo.co.kr

Clinical Cardiology
|February 12, 2005
PubMed

Insights

C-reactive protein (CRP) and intercellular adhesion molecule-1 (ICAM-1) predict cardiac events in unstable angina patients post-stenting. Elevated CRP and ICAM-1 levels indicate higher risk, suggesting CRP

Area of Science:

  • Cardiology
  • Inflammation Research
  • Atherosclerosis Studies

Background:

  • Growing evidence suggests C-reactive protein (CRP) plays a direct role in atherosclerosis.
  • Inflammatory markers are increasingly recognized as significant in cardiovascular disease pathogenesis.

Purpose of the Study:

  • To assess associations between CRP and adhesion molecules.
  • To determine the prognostic value of adhesion molecules in predicting cardiac events.
  • To evaluate these markers in patients with unstable angina undergoing coronary stenting.

Main Methods:

  • Study included 55 unstable angina patients (Braunwald class IIb or IIIb) undergoing coronary stenting.
  • Measured CRP and intercellular adhesion molecule-1 (ICAM-1) levels.
  • Utilized multiple linear regression analysis and assessed prognostic value for cardiac events.

Main Results:

  • A significant trend showed increasing ICAM-1 concentrations with higher CRP levels at 72 hours post-stenting (p=0.03).
  • CRP levels were the sole determinant of ICAM-1 concentrations at 72 hours.
  • Elevated CRP (>5.4 mg/l) and ICAM-1 (>321 ng/ml) independently predicted adverse cardiac events (p<0.05).

Conclusions:

  • CRP and ICAM-1 measurements are valuable for risk stratification in unstable angina patients post-stenting.
  • CRP may directly contribute to atherosclerosis by inducing ICAM-1 expression.
  • These inflammatory markers identify patients at higher risk for cardiac events.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...